Related references
Note: Only part of the references are listed.PHASE 3, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ERENUMAB (AMG 334) IN MIGRAINE PREVENTION: PRIMARY RESULTS OF THE STRIVE TRIAL
Peter J. Goadsby et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2017)
Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
Stewart Tepper et al.
LANCET NEUROLOGY (2017)
Pharmacokinetic-Pharmacodynamic Relationship of Erenumab (AMG 334) and Capsaicin-Induced Dermal Blood Flow in Healthy and Migraine Subjects
Thuy Vu et al.
PHARMACEUTICAL RESEARCH (2017)
Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial
Hong Sun et al.
LANCET NEUROLOGY (2016)
The Prevalence and Burden of Migraine and Severe Headache in the United States: Updated Statistics From Government Health Surveillance Studies
Rebecca C. Burch et al.
HEADACHE (2015)
Pharmacological characterization of rat amylin receptors: implications for the identification of amylin receptor subtypes
R. J. Bailey et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
A Randomized, Placebo-Controlled Study of the Effects of Telcagepant on Exercise Time in Patients With Stable Angina
B. R. Chaitman et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Migraine prevalence by age and sex in the United States: A life-span study
T. W. Victor et al.
CEPHALALGIA (2010)
Calcitonin Gene-Related Peptide Receptor Antagonism Does Not Affect the Severity of Myocardial Ischemia during Atrial Pacing in Dogs with Coronary Artery Stenosis
Christopher P. Regan et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
The role of calcitonin gene-related peptide (CGRP) in ischemic preconditioning in isolated rat hearts
WX Chai et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
The effect of tadalafil on the time to exercise-induced myocardial ischaemia in subjects with coronary artery disease
D Patterson et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2005)
The molecular pharmacology of CGRP and related peptide receptor subtypes
C Juaneda et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2000)
Potential of calcitonin gene-related peptide in coronary heart disease
A Franco-Cereceda et al.
PHARMACOLOGY (2000)
Share Paper
